U.S. Water Utilities Stock News

NasdaqGS:CSWC
NasdaqGS:CSWCCapital Markets

Is Capital Southwest’s New Off‑Balance Sheet Credit JV Reshaping The Investment Case For CSWC?

Capital Southwest Corporation recently formed an off‑balance sheet joint venture with another private credit asset manager to invest primarily in first out senior secured debt in the lower middle market, with each party holding a 50% equity interest and equal representation on the joint venture’s board of managers. This structure allows Capital Southwest to potentially expand its private credit reach and deal flow while sharing investment risk and funding through an anticipated senior...
NYSE:CHD
NYSE:CHDHousehold Products

Should Church & Dwight’s Portfolio Shift, Innovation Push, and Higher Payout Guide CHD Investors’ Next Move?

In late January 2026, Church & Dwight reported fourth-quarter and full-year 2025 results showing higher sales and earnings, issued 2026 guidance calling for a small reported sales decline tied to 2025 business exits but higher diluted EPS, raised its quarterly dividend by 4.2%, and completed a US$771.12 million share repurchase program. The company also highlighted that new products are expected to contribute roughly half of organic growth in 2026, underscoring how innovation across brands...
NYSE:EOG
NYSE:EOGOil and Gas

Is It Time To Reassess EOG Resources (EOG) After Recent Share Price Recovery?

If you are wondering whether EOG Resources at around US$112 per share still offers value, you are not alone. This article will focus on what the numbers say about that question. The stock has returned 3.5% over the last 7 days and 4.5% over the last 30 days, while the 1 year return stands at a 7.6% decline and the 5 year return is 152.9%. Recent market attention on EOG Resources has centered on how energy names are being priced against long term commodity expectations and capital allocation...
NasdaqCM:NEGG
NasdaqCM:NEGGSpecialty Retail

How Investors Are Reacting To Newegg Commerce (NEGG) Chairman’s Detention And Governance Investigation

In late January 2026, The Schall Law Firm announced an investigation into Newegg Commerce over potential securities law violations after the company disclosed that its chairman and controlling shareholder, He Zhitao, had been detained and placed under investigation. This development raises pointed questions about Newegg’s governance structure and leadership continuity, given the central role of a single controlling shareholder. We’ll now examine how the chairman’s detention and related...
NasdaqGS:CLBK
NasdaqGS:CLBKBanks

A Look At Columbia Financial (CLBK) Valuation After Key Executive Leadership Changes

Columbia Financial (CLBK) has reshaped its senior leadership, promoting Dennis E. Gibney to First Senior Executive Vice President and Chief Banking Officer and naming Thomas Splaine, Jr. as Executive Vice President and Chief Financial Officer. See our latest analysis for Columbia Financial. At a share price of $16.27, Columbia Financial has seen its short term momentum pick up, with a 30 day share price return of 5.51% and a 1 year total shareholder return of 10.01%, although the 3 year total...
NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Index Move To S&P 400 Might Change The Case For Investing In Advanced Energy Industries (AEIS)

In late January 2026, Advanced Energy Industries was removed from the S&P 600 and S&P 600 Information Technology indices and simultaneously added to the S&P 400 and S&P 400 Information Technology indices as part of an index rebalancing. This index migration shifts the company into a mid-cap benchmark, potentially altering its investor base as passive funds and ETFs adjust their holdings to reflect the new index alignment. Next, we examine how Advanced Energy Industries’ move from the S&P 600...
NYSE:GIS
NYSE:GISFood

How Investors Are Reacting To General Mills (GIS) Recall, Governance Changes, and Dividend Declaration

In late January 2026, General Mills expanded its Canadian recall of select Pillsbury Pizza Pops due to potential E. coli contamination, while its board amended and restated the company’s bylaws and declared a US$0.61 quarterly dividend payable on May 1, 2026. Alongside these moves, the appointment of Hyatt CFO Joan Bottarini as an independent director highlights General Mills’ focus on board expertise, governance refinement, and continued capital returns. Next, we’ll examine how Joan...
NYSE:PARR
NYSE:PARROil and Gas

Par Pacific Holdings (PARR) Valuation After Venezuela Policy Shifts And Analyst Outlook Changes

Policy shifts, analyst commentary and recent share price move Recent US policy action in Venezuela and the prospect of higher Venezuelan crude flows to Gulf Coast refineries have put Par Pacific Holdings (PARR) on investors’ radar, especially after a 4.5% share price decline in mid January. See our latest analysis for Par Pacific Holdings. That recent mid January share price drop sits against a mixed backdrop, with a 7 day share price return of 7.19%, a 30 day share price return of 5.36%,...
NYSE:GXO
NYSE:GXOLogistics

Is GXO Logistics (GXO) Fairly Priced After Its Recent 24.5% Share Price Gain

If you are wondering whether GXO Logistics is still reasonably priced after its recent run, you are not alone. This article walks through what the current share price might be implying about the company. Over the last year, the stock has returned 24.5%, with a 4.2% return over the past month and a 1.4% decline over the last week from a recent close of US$56.59. These moves can change how investors think about both upside and risk. Recent news flow around GXO Logistics has focused on its role...
NYSE:LAD
NYSE:LADSpecialty Retail

Assessing Lithia Motors (LAD) Valuation After Mixed Returns And Reported Undervaluation

Lithia Motors (LAD) is back in focus after recent share price moves, with the stock closing at $323.44 as investors weigh its valuation against reported revenue of $37.61b and net income of $900.7m. See our latest analysis for Lithia Motors. Recent trading has been mixed, with a 4.94% 3 month share price return but a 1 year total shareholder return decline of 13.37%, suggesting longer term momentum has faded even as shorter term moves remain more constructive. If Lithia Motors has you...
NYSE:AROC
NYSE:AROCEnergy Services

Does Archrock’s (AROC) Higher Dividend Reveal a Durable Cash Engine or Limited Reinvestment Ambition?

Archrock, Inc. recently announced that its Board of Directors has raised the quarterly dividend to US$0.22 per share, or US$0.88 on an annualized basis, payable on February 18, 2026 to shareholders of record as of February 10, 2026. This higher payout, following increases over both the prior quarter and the same period last year, underlines management’s confidence in Archrock’s cash generation and commitment to shareholder returns. Next, we’ll examine how this dividend increase shapes...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Should Insider Selling Amid Rusfertide Progress and Icotrokinra Advances Require Action From Protagonist Therapeutics (PTGX) Investors?

In recent weeks, Protagonist Therapeutics has reported insider share sales by senior executives alongside progress updates on rusfertide’s New Drug Application and advancing icotrokinra toward potential approval. At the same time, a broad group of Wall Street firms has become more optimistic on Protagonist’s lead drug candidates, reflecting growing confidence in the company’s clinical and regulatory trajectory despite insider transactions largely tied to tax and option exercises. With...
NYSE:LEN
NYSE:LENConsumer Durables

Lennar’s Margin Slippage and 55-Plus Expansion: What Story Do They Tell About LEN’s Strategy?

Lennar recently reported fiscal fourth-quarter 2025 results showing year-over-year declines in revenue, earnings per share, and profit margins, even as operating cash flow strengthened. Away from the headline numbers, Lennar is simultaneously expanding its 55-and-better footprint with the Dry Canyon community in Central Oregon and continuing shareholder returns via a US$0.50 quarterly dividend. We will now examine how the combination of weaker quarterly profitability and the Dry Canyon...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

Is Beam Therapeutics’ (BEAM) Alpha-1 Update Quietly Reframing the Story of Its Gene-Editing Platform?

In recent days, Beam Therapeutics received a favorable regulatory update for its Alpha-1 Antitrypsin Deficiency program, while Bernstein reiterated a positive stance and ARK Investment Management added 116,000 shares, alongside the company outlining 2026 priorities to advance its genetic medicines pipeline. An additional development was the open-market sale of 6,198 shares by Senior Vice President Bethany J. Cavanagh under a pre-arranged Rule 10b5-1 trading plan, offering investors a window...
NasdaqCM:BFC
NasdaqCM:BFCBanks

Assessing Bank First (BFC) Valuation After Strong Q4 Results And An 11.1% Dividend Increase

Bank First (BFC) just paired its fourth quarter earnings report with a higher payout to shareholders, reporting increases in net interest income, net income, and an 11.1% bump in its quarterly dividend. See our latest analysis for Bank First. At a share price of $139.54, Bank First has logged a 15.68% year to date share price return and a 44.36% total shareholder return over the past year, suggesting recent momentum has been building alongside its earnings, dividend increase, and board...
NYSE:INSW
NYSE:INSWOil and Gas

How International Seaways’ Fleet Sales and Tankers International Deal Will Impact International Seaways (INSW) Investors

International Seaways recently agreed to sell five of its oldest tankers, three MR and two VLCC vessels, for about US$185,000,000, with the deals expected to close in the first quarter of 2026 and generate gains of roughly US$65,000,000. On January 27, 2026, the company also took full ownership of Tankers International and expanded into the Suezmax market, underscoring an active shift toward fleet renewal, capital recycling and a broader role in global crude transportation. We’ll now examine...
NYSE:KD
NYSE:KDIT

Assessing Kyndryl Holdings (KD) Valuation After New SAP CoE Launch And Extended Hertz Partnership

Kyndryl Holdings (KD) has been in focus after unveiling its SAP Transformations Center of Excellence, along with new AI driven SAP modernization services and a five year extension of its technology partnership with Hertz. See our latest analysis for Kyndryl Holdings. Despite a stream of AI focused SAP announcements and the extended Hertz partnership, Kyndryl Holdings' recent share price momentum has been weak. The 30 day share price return is 9.77% and the 1 year total shareholder return is...
NYSE:DAR
NYSE:DARFood

Why Darling Ingredients (DAR) Is Up 6.8% After Renewable Diesel Drives Surprise Quarterly Profit – And What's Next

In its most recent quarter, Darling Ingredients reported US$55 million in net income despite a full-year operating loss of US$156 million, with the renewable diesel segment alone contributing US$92 million of income. Management highlighted sequential improvements and voiced renewed confidence in both renewable diesel and core ingredients, signaling a potential inflection in how the business mix supports overall earnings resilience. Next, we will examine how the renewable diesel segment’s...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

Assessing RadNet (RDNT) Valuation After Recent Share Price Softness

Event overview and why RadNet is on investors’ radar RadNet (RDNT) has caught investor attention after recent trading performance. The stock is down 0.9% over the past week and 10% over the past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for RadNet. Looking beyond the recent pullback, RadNet’s share price return over the past 3 months has softened. Its 1 year total shareholder return of 7.1% and very large 3 and 5 year total shareholder returns point to...
NasdaqGS:OLMA
NasdaqGS:OLMABiotechs

A Look At Olema Pharmaceuticals (OLMA) Valuation After Renewed Buy Ratings And Phase 3 Breast Cancer Plans

Olema Pharmaceuticals (OLMA) is back on trader watchlists after recent analyst commentary around its breast cancer pipeline and management’s confirmation that key clinical milestones remain on schedule through 2026. See our latest analysis for Olema Pharmaceuticals. At a share price of US$25.72, Olema has eased back slightly in the last session, but its roughly 205% 90 day share price return and very large 1 year total shareholder return suggest momentum has been building as investors weigh...
NYSE:NVT
NYSE:NVTElectrical

A Look At nVent Electric’s (NVT) Valuation After Recent Share Price Swings

Why nVent Electric is on investors’ radar today nVent Electric (NVT) is drawing interest after a recent share price move that leaves the stock with a 1 day return of about a 3% decline and a month gain near 5%. Those short term swings sit alongside a past 3 months return that is roughly flat and a 1 year total return above 70%. This is prompting investors to reassess what current pricing implies for the business. See our latest analysis for nVent Electric. The recent 1 day share price decline...
NYSE:UDR
NYSE:UDRResidential REITs

Assessing UDR (UDR) Valuation As Analysts See Modest Undervaluation Despite High P/E Multiple

UDR (UDR) is back on investors’ radar after a recent price move that leaves the stock about 8.8% below aggregate analyst expectations. This has prompted a closer look at its returns and fundamentals. See our latest analysis for UDR. With the share price at $37.15, UDR’s recent 0.65% 1 day share price return and 9.94% 90 day share price return point to improving momentum, even though the 1 year total shareholder return of 6.92% decline shows a weaker longer term experience for investors. If...
NYSE:AZZ
NYSE:AZZBuilding

Is AZZ’s New US$100 Million Buyback Program Reframing Its Capital Allocation Story (AZZ)?

AZZ Inc. recently announced that its Board of Directors approved a new 2026 Share Repurchase Program authorizing up to US$100 million of common stock repurchases, primarily to offset dilution from employee equity grants and operating alongside its prior authorization. This incremental buyback capacity, paired with management’s explicit confidence in AZZ’s operations and balance sheet, highlights a clear capital allocation preference toward share repurchases at current market...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

Will Stoke’s New Waltham Headquarters for Zorevunersen Commercialization Shift Stoke Therapeutics' (STOK) Narrative?

In January 2026, Stoke Therapeutics entered into a long-term lease for a new 98,500 square-foot headquarters and laboratory at 245 Fifth Avenue in Waltham, Massachusetts, with aggregate estimated base rent of about US$85.5 million through March 31, 2038. This expanded facility, backed by a US$3 million security deposit, is intended to support Stoke’s preparations to commercialize its potential Dravet syndrome medicine, zorevunersen, and broaden research based on its proprietary...